pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,022 catalysts · 7,021 phase readout · 2,430 8k filing · 386 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: filing×type: adcom×type: phase readout×clear all
type
  • phase readout7,021
  • 8k filing2,430
  • earnings386
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07607444: CBT-I in Physically Active Participants With Insomnia Complaints

Sponsor: Federal University of Jatai. Phase: NA. Conditions: Insomnia

full page →ctgov ↗
›COMPLETEDphase readoutNCT05801809: Understanding the Effects of Transauricular Vagus Nerve Stimulation on Neural Networks and Autonomic Nervous System

Sponsor: Spaulding Rehabilitation Hospital. Phase: NA. Conditions: Healthy Volunteers

full page →ctgov ↗
›RECRUITINGphase readoutNCT07341009: Evaluation of a Neuropsychological Tool to Assess Temporal Processing Abilities in Alzheimer's Disease

Sponsor: University Hospital, Caen. Phase: . Conditions: Alzheimer's Disease (AD), Time Perception

full page →ctgov ↗
›RECRUITINGphase readoutNCT06246799: Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

Sponsor: The University of Texas Health Science Center at San Antonio. Phase: PHASE3. Conditions: Type 2 Diabetes (Adult Onset)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06948799: A Study to Evaluate the Safety and Tolerability of Single and Multiple Dose of STSP-0902 in Healthy Subjects

Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd. Phase: PHASE1. Conditions: Oligozoospermia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01808599: Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma

Sponsor: International Extranodal Lymphoma Study Group (IELSG). Phase: PHASE2. Conditions: MALT Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07322432: The CONQUER Trial - Cessation Of Nicotine, QUitting With E-cigarette Reduction

Sponsor: VapeAway. Phase: PHASE2. Conditions: Addiction Nicotine

full page →ctgov ↗
›COMPLETEDphase readoutNCT04167163: Abaloparatide Before Total Knee Arthroplasty

Sponsor: University of Wisconsin, Madison. Phase: PHASE4. Conditions: Osteoporosis, Arthroplasties, Knee Replacement

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02960087: Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

Sponsor: Canadian Cancer Trials Group. Phase: NA. Conditions: Prostate Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07690787: JS207 a Bispecific Antibody Against PD1-VEGF in Nasopharyngeal Carcinoma

Sponsor: Chinese University of Hong Kong. Phase: PHASE2. Conditions: Recurrent/ Metastatic NPC

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06917287: A Clinical Study to Evaluate the Efficacy of Native CT-II® in Individuals With Knee Osteoarthritis

Sponsor: Vedic Lifesciences Pvt. Ltd.. Phase: NA. Conditions: Knee Osteoarthritis (OA)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07373093: Predictors of Measles Vaccine Hesitancy in New York State

Sponsor: Albany Medical College. Phase: . Conditions: Measles Vaccination

full page →ctgov ↗
›RECRUITINGphase readoutNCT07535593: Transcutaneous Electrical Acupoint Stimulation at Jing-Well Points for Disorders of Consciousness

Sponsor: Xijing Hospital. Phase: PHASE2. Conditions: Disorders of Consciousness Due to Severe Brain Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT07505693: The Effect of Health Belief Model-Based Education on Knowledge and Behavioral Changes Regarding Dementia in Older Adults

Sponsor: Hasan Kalyoncu University. Phase: NA. Conditions: Aged 60 Years or Older, Volunteering to Participate in the Study, Dementia Education, Prevention Intervention

full page →ctgov ↗
›COMPLETEDphase readoutNCT03409614: Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07253116: A Phase I/II Clinical Study of WJ22096 Tablets in Patients With Advanced Tumors

Sponsor: Nanjing Jingao biomidical technology Co. Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT05706116: Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults

Sponsor: George Washington University. Phase: PHASE1. Conditions: Whipworm, Trichuriasis, Controlled Human Infection

full page →ctgov ↗
›COMPLETEDphase readoutNCT05999006: Safety and Feasibility of the ELIOS System in POAG Patients

Sponsor: Elios Vision, Inc.. Phase: NA. Conditions: Glaucoma, Primary Open Angle

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06023004: The Diverticulitis Study

Sponsor: University of Aarhus. Phase: . Conditions: Colonic Diverticulitis, Colorectal Cancer, Acute Diverticulitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07215949: Zilucoplan for Severe gMG Exacerbations

Sponsor: Miriam Freimer. Phase: PHASE3. Conditions: Generalized Myasthenia Gravis (gMG)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06192758: Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device

Sponsor: Boston Scientific Corporation. Phase: NA. Conditions: Prostate, Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05687058: Empagliflozin in ESKD - A Feasibility Study

Sponsor: University of Mississippi Medical Center. Phase: PHASE1. Conditions: Kidney Failure, Chronic, Heart Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT04932148: INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD)

Sponsor: The University of Queensland. Phase: NA. Conditions: Kidney Failure

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07318948: BALANCE Trial Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

Sponsor: Bo Wu. Phase: NA. Conditions: Acute Ischemic Stroke

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05736848: A Retrospective Assessment of OviTex PRS (OviTex)

Sponsor: Tela Bio Inc. Phase: . Conditions: Reconstructive Surgical Procedures

full page →ctgov ↗
›COMPLETEDphase readoutNCT06975449: Effectiveness of Graded Training in the Vivifrail Exercise Program Among Long-Term Care Residents

Sponsor: China Medical University Hospital. Phase: NA. Conditions: Frailty, Physical Inactivity, Aging

full page →ctgov ↗
›RECRUITINGphase readoutNCT07651358: A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

Sponsor: OHSU Knight Cancer Institute. Phase: NA. Conditions: Stage I Pancreatic Cancer AJCC v8, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8

full page →ctgov ↗
›RECRUITINGphase readoutNCT07246148: NOn-inVAsive Blood Pressure Monitoring in Intracranial Aneurysm Embolization

Sponsor: Korea University Anam Hospital. Phase: NA. Conditions: Cerebral Aneurysms, Intracranial Aneurysms, Coil Embolization, Hemodynamic Instability, Noninvasive Cardiac Monitoring

full page →ctgov ↗
›RECRUITINGphase readoutNCT07606755: Clinical Efficacy Study of Jinfeng Pill in the Treatment of Perimenopausal Syndrome

Sponsor: Tongji Hospital. Phase: PHASE4. Conditions: Perimenopausal Syndrome

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03484130: Prospective Phenotyping of Autonomous Aldosterone Secretion

Sponsor: Brigham and Women's Hospital. Phase: . Conditions: Aldosterone Disorder, Adrenal Gland Disease, Blood Pressure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07432828: Assessment of the Association Between Sleep Disorders Detected by a Simplified Questionnaire and Cardiovascular Diseases

Sponsor: French Cardiology Society. Phase: . Conditions: Sleep Disorder (Disorder), Cardio Vascular Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07038928: TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation

Sponsor: AstraZeneca. Phase: . Conditions: Bladder Cancer

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07527065: Comparison of TAP and QL Blocks for Postoperative Analgesia in Open Inguinal Hernia Repair

Sponsor: Hitit University. Phase: NA. Conditions: Postoperative Pain

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07608367: A Single-Center Clinical Study to Evaluate the Efficacy and Safety of a Suture-Free Ophthalmic Hydrogel for Ocular Surface Tissue Adhesion

Sponsor: Suxia Li. Phase: NA. Conditions: Cornea Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06704100: Oral Fosamprenavir + Sodium Alginate for GERD

Sponsor: Medical College of Wisconsin. Phase: PHASE2. Conditions: Refractory Gastroesophageal Reflux Disease, Gastroesophageal Reflux Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07238400: Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia

Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Hypertension

full page →ctgov ↗
›TERMINATEDphase readoutNCT00788307: Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to Radiation Therapy

Sponsor: Mayo Clinic. Phase: PHASE1. Conditions: Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07570992: A Research Study to Evaluate the Safety of NNC1679-0001 When Given to Healthy Participants and Participants With T2DM

Sponsor: Novo Nordisk A/S. Phase: PHASE1. Conditions: Healthy Volunteers, Diabetes Mellitus, Type 2

full page →ctgov ↗
›COMPLETEDphase readoutNCT00480792: Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients

Sponsor: ANRS, Emerging Infectious Diseases. Phase: PHASE3. Conditions: HIV Infections

full page →ctgov ↗
›RECRUITINGphase readoutNCT07219511: A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

Sponsor: Vasa Therapeutics. Phase: PHASE1. Conditions: Heart, Heart Failure With Preserved Ejection Fraction (HFPEF)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07440511: Spleen Stiffness Measurement for the Detection of Advanced Fibrosis

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07403071: Validating Fish Oil's Role in Alleviating Bortezomib-Induced Neuropathy: A Multi-Method Study Integrating Big Data, Experimental, and Clinical Research

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School. Phase: . Conditions: Multiple Myeloma, Peripheral Neuropathy Due to Chemotherapy

full page →ctgov ↗
›TERMINATEDphase readoutNCT02827071: Ocular Imaging Study Using Advanced OCT

Sponsor: University of California, Los Angeles. Phase: . Conditions: Retinal Vascular Disorder, Macular Degeneration

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07782671: The NICE-PAD II Trial

Sponsor: Northwestern University. Phase: PHASE3. Conditions: Peripheral Artery Disease (PAD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT04338971: Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes

Sponsor: Neurolutions, Inc.. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03366844: Breast Cancer Study of Preoperative Pembrolizumab + Radiation

Sponsor: Stephen Shiao. Phase: PHASE1. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07015034: Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice

Sponsor: University of Copenhagen. Phase: NA. Conditions: Vision Impairment and Blindness, Glaucoma, Age-Related Macular Degeneration, Cataract, Diabetic Retinopathy

full page →ctgov ↗
›TERMINATEDphase readoutNCT03865264: Living Organ Donor Recovery Enhancement Program

Sponsor: Baylor Research Institute. Phase: NA. Conditions: Living Liver and Kidney Donors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07396064: Bridging the Gap: Enhancing Cancer Care for Underserved Populations With the Veris Health Cancer Care Platform

Sponsor: VERIS HEALTH INC. Phase: . Conditions: Cancer Care Recipient, Observational Study

full page →ctgov ↗
›RECRUITINGphase readoutNCT07460232: FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

Sponsor: Mayo Clinic. Phase: EARLY_PHASE1. Conditions: Cushing Disease, Pituitary Adenoma

full page →ctgov ↗
← prev
page 140 of 141
next →